Data / Form D filings / Intolerant Antibodies, Inc.
Intolerant Antibodies, Inc.: Form D filing
Intolerant Antibodies, Inc., a company in South San Francisco, CA, filed a Form D with the SEC in 2024. The latest, on June 12, 2024, reports $1.1 million sold of a $1.1 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 329 OYSTER POINT BLVD. 3RD FLOOR, South San Francisco, CA, 94080
- Phone
- (617) 308-5297
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- California
- Year incorporated
- 2024
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2026465
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2024 | New notice | $1,099,998 | $1,099,998 | 4 | May 8, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Maryam Shansab | Executive Officer, Director |
Other companies in California that filed recently
- Crosscut SPV Frontier LP - Series 2 $23.4 million · Oct 30, 2026
- Series 23-1, a series of StartEngine Private Funds LLC $314,025 · Oct 30, 2026
- Omnissa Holdco LLC offering · Oct 30, 2026
- Angle Health, Inc. $591.5 million · Oct 29, 2026
- Agilis Medical, Inc. $4 million · Oct 28, 2026
- Bridgeview Innovations, Inc. $10.3 million · Oct 28, 2026
Every Form D from the week of Jun 10, 2024 · All recent filings in California · All recent Other filings
Read from SEC EDGAR. Amount sold is what Intolerant Antibodies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.